BAM
MRNA icon

Beaumont Asset Management’s Moderna MRNA Stock Holding History

Beaumont Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,002
Closed -$517K – 67
2022
Q1 		$517K Buy
3,002
+69
+2% +$11.6K 0.35% 50
2021
Q4 		$744K Buy
2,933
+120
+4% +$35.1K 0.5% 35
2021
Q3 		$1.08M Buy
2,813
+31
+1% +$11.4K 0.81% 23
2021
Q2 		$653K Buy
2,782
+986
+55% +$176K 0.5% 35
2021
Q1 		$235K Buy
+1,796
New +$260K 0.2% 59

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beaumont Asset Management's MRNA Position: Q2 2022 in Review

Beaumont Asset Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 3,002 shares — an estimated $517K sold.

Beaumont Asset Management first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $1.08M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Beaumont Asset Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Beaumont Asset Management sold 3,002 Moderna shares in Q2 2022, an estimated $517K.
  • Beaumont Asset Management first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
  • Beaumont Asset Management's Moderna position peaked at $1.08M in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Beaumont Asset Management's 13F filing for Q2 2022, filed 19 Jul 2022.